1-3 of 3
Hearn Jay Cho
Close
Sort by
Journal Articles

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups

Clinical Trials & Observations
Urvi A. Shah, Erin Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn R. Tan, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud, Larysa Sanchez, Cesar Rodriguez, Shambavi Richard, Joshua Richter, Adriana Rossi, Hearn Jay Cho, Alexander Lesokhin, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Samir Parekh, Emily J. Gallagher
Journal: Blood Advances
Blood Adv (2024) 8 (1): 236–247.
https://doi.org/10.1182/bloodadvances.2023010815
Published: 2024
Includes: Supplemental data
Journal Articles

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Tarek H. Mouhieddine, Oliver Van Oekelen, David T. Melnekoff, Jeanne Li, Yogita Ghodke-Puranik, Guido Lancman, Santiago Thibaud, Darren Pan, Sridevi Rajeeve, Sarita Agte, Adolfo Aleman, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez, Alessandro Lagana, Erin Moshier, Ajai Chari, Sundar Jagannath, Samir Parekh
Journal: Blood Advances
Blood Adv (2023) 7 (6): 1056–1064.
https://doi.org/10.1182/bloodadvances.2022007923
Published: 2023
Includes: Supplemental data
Journal Articles

Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling

Clinical Trials & Observations
Vernon Wu, Erin Moshier, Siyang Leng, Bart Barlogie, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Madhu Mazumdar, Samir Parekh, Ajai Chari
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1470–1479.
https://doi.org/10.1182/bloodadvances.2018016998
Published: 2018